-
Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
Cons
Performance of Advanced Proteome Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | -0.760% | -1.515% | -2.985% | -15.033% | -21.687% | -53.982% | -81.944% |
| Celldex Therapeutics | 2.590% | 1.020% | -9.174% | -9.174% | -10.000% | -50.276% | -10.891% |
| Achieve Life Sciences Inc. | 4.300% | 6.277% | -25.333% | 20.530% | -1.622% | -28.205% | -67.207% |
News
AMD Responds to Rumors About Potential Delays
In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD) and other AI stocks. To learn more, check out the short video, consider subscribing, and click the special
AMD Shareholders Received Amazing News From a Massive New Customer
In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD) and other AI stocks. To learn more, check out the short video, consider subscribing, and click the special
3 Predictions for Advanced Micro Devices in 2026
It's been a disappointing past few months for shareholders in Advanced Micro Devices (NASDAQ: AMD). After soaring in early October on news that the company will be supplying processing chips for


